Trials / Conditions / Thymidine Kinase 2 Deficiency
Thymidine Kinase 2 Deficiency
4 registered clinical trials studyying Thymidine Kinase 2 Deficiency.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | A Study of the Efficacy and Safety of MT1621 in Thymidine Kinase 2 (TK2) Deficiency (Treatment naïve) NCT04581733 | Zogenix MDS, Inc. | Phase 3 |
| Completed | A Retrospective Study of Subjects With Thymidine Kinase 2 Deficiency NCT05017818 | Zogenix MDS, Inc. | — |
| Active Not Recruiting | An Open-Label Study of Continuation Treatment With Combination Pyrimidine Nucleosides in Patients With TK2 Def NCT03845712 | UCB BIOSCIENCES, Inc. | Phase 2 |
| Active Not Recruiting | Treatment of TK2 Deficiency With Thymidine and Deoxycytidine NCT03639701 | Columbia University | Phase 1 / Phase 2 |